![Kuan Chu Ko](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kuan Chu Ko
Corporate Officer/Principal at CytoPharm, Inc.
Profile
Kuan Chu Ko is currently working as a Manager-Pharmaceutical Regulations at CytoPharm, Inc. Prior to this, he completed his undergraduate degree from Fooyin University.
Kuan Chu Ko active positions
Companies | Position | Start |
---|---|---|
CytoPharm, Inc.
![]() CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 22/09/2011 |
Training of Kuan Chu Ko
Fooyin University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
CytoPharm, Inc.
![]() CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Kuan Chu Ko